UBS Reiterates Neutral Rating on Carter's (CRI), Expects Solid Q1 Results
Tweet Send to a Friend
UBS analyst Jay Sole reiterated a Neutral rating and $40.00 price target on Carter's (NYSE: CRI).The analyst commented, "Our checks ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
